Chemical industry – Page 2
-
OpinionSafety is everyone’s responsibility
Maintaining culture and investment is key, especially in the absence of incidents
-
BusinessCrispr Nobel laureates get another chance to claim ownership in long-running patent dispute
Jennifer Doudna and Emmanualle Charpentier could recoup patent rights to the gene-editing technology, thanks to ruling from US appeal court
-
ResearchPolymer membrane separates hydrocarbons, offering alternative to distillation
Microporous membrane enables energy efficient chemical separations
-
BusinessExplosion and fire at Chinese chemical plant kills five
Six others missing and 19 injured at Shandong Youdao Chemical
-
OpinionIgnoring women’s health shouldn’t be an option
Developing therapies for conditions that predominantly affect women is a neglected, but enormous, opportunity
-
OpinionWomen are not just another confounding factor in drug development
Ignoring physiological differences between the sexes is indefensible
-
BusinessTrade deals stave off Trump’s tariffs temporarily
Initial agreements with China and UK have paused trade war, but uncertainty reigns
-
BusinessUS approves natural food dyes while pushing to phase out synthetic colours
Government sets voluntary goal of removing artificial colours by 2027
-
OpinionRebuilding pharma supply chains
Multinationals are promising huge US investments, but it’s not all because of Trump’s policies
-
OpinionIran port explosion highlights issues of shipping hazardous chemicals
Intersecting regulations and jurisdictions mean rules can be accidentally or deliberately overlooked
-
BusinessAt least 70 dead in Iran port explosion and fire
More than 1000 people injured after cargo caught fire and exploded
-
OpinionIn search of truth and rules
To codify and predict ever more complex phenomena is one of science’s great drivers
-
BusinessMerck KGaA to buy cancer specialist SpringWorks
$3.9 billion deal boosts Merck’s pipeline as it faces patent expiries
-
BusinessGilead settles US HIV drug kickback lawsuit
Firm will pay $202 million to federal and state governments
-
OpinionGiving companies room to grow
Can shopping centres and offices become urban lab spaces for innovative companies to grow and scale-up?
-
BusinessOut of the suburbs: the rise of urban labs
Could empty office blocks and shopping centres provide much-needed space for growing companies?
-
BusinessThe problem of scale-up in the UK
What’s the point of knowledge generation if we’re not creating high value jobs, asks Chris Kay
-
BusinessThe hole in the UK chemical industry
Norman Keane thinks ICI’s breakup has left a gap in scale-up knowhow and skills, as well as a lack of facilites
-
OpinionPolymorphs matter – especially when they might disappear
Disappearing polymorphs offer a fascinating example of the dark arts of crystallisation
-
NewsFears grow over the future of mRNA vaccine research in the US
Researchers working on mRNA vaccines fear federal funding might be halted, with many looking to move projects abroad